Does Honeywell’s Aerospace Spin Off And Defense Tilt Reshape The Bull Case For Honeywell (HON)?

Honeywell International Inc.

Honeywell International Inc.

HON

0.00

  • Honeywell International recently presented at CeMAT Southeast Asia 2026 and detailed the pending spin-off of its aerospace unit amid restructuring costs, soft Q2 revenue expectations, and reaffirmed full-year 2026 guidance.
  • The separation of Honeywell’s automation and aerospace businesses, alongside rising demand for its defense-related products in a tense geopolitical backdrop, marks a meaningful shift in how investors may view the company’s future profile and risk mix.
  • We’ll now examine how Honeywell’s upcoming aerospace spin-off and heightened defense demand could reshape its existing investment narrative.

Find 46 companies with promising cash flow potential yet trading below their fair value.

Honeywell International Investment Narrative Recap

To own Honeywell here, you mainly need to believe the planned break-up and automation focus can still create value despite softer near term results and spin related noise. The latest CeMAT appearance, Q2 revenue caution and ongoing restructuring look more like confirmation of existing short term pressures than a new catalyst. The biggest near term swing factor remains how cleanly Honeywell executes the aerospace spin off, while elevated restructuring and separation costs are the most immediate risk.

Against that backdrop, the upcoming aerospace spin and rising defense demand are central. Honeywell’s new multi year US$500 million defense framework with the U.S. Department of War, focused on navigation systems and electronic warfare solutions, points to a potentially larger role for the stand alone aerospace business once listed. For current shareholders, this combination of portfolio reshaping and defense exposure could prove important to how the remaining Honeywell is valued after the spin.

Yet, beneath the separation story, investors should also be aware of how substantial one time spin costs and tariff exposure could...

Honeywell International's narrative projects $44.8 billion revenue and $7.2 billion earnings by 2029. This requires 5.9% yearly revenue growth and a $3.2 billion earnings increase from $4.0 billion today.

Uncover how Honeywell International's forecasts yield a $247.90 fair value, a 14% upside to its current price.

Exploring Other Perspectives

HON 1-Year Stock Price Chart
HON 1-Year Stock Price Chart

While the base case focuses on value from the spin, the most cautious analysts assume slower 4.8 percent annual revenue growth and only US$6.9 billion of earnings by 2029, so this new information could lead you to rethink which narrative you agree with.

Explore 7 other fair value estimates on Honeywell International - why the stock might be worth 8% less than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Honeywell International research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Honeywell International research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Honeywell International's overall financial health at a glance.

Curious About Other Options?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • Capitalize on the AI infrastructure supercycle with our selection of the 39 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • Rare earth metals are the new gold rush. Find out which 33 stocks are leading the charge.
  • We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.